Denali Therapeutics  logo
Denali Therapeutics DNLI
$ 18.99 -10.66%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Denali Therapeutics EV/EBITDA Ratio 2011-2025 | DNLI

Annual EV/EBITDA Ratio Denali Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-14.1 84.8 -10.5 -43 -1.56 - - - - - -
20222022202120212020202020192019201820182017201720162016201520152014201420132013201220122011201190906060303000-30-30-60-60
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
84.8 -43 3.15